Adrenocortical carcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
Risk factor associated with adrenocortical carcinoma are: | Risk factor associated with adrenocortical carcinoma are: | ||
* [[Lynch syndrome]] | * [[Lynch syndrome]] | ||
*[[Beckwith-Wiedemann syndrome]] | *[[Beckwith-Wiedemann syndrome]] ([[Beckwith-Wiedemann syndrome|BWS]]) | ||
*[[Carney complex]] | *[[Carney complex]] | ||
*[[Neurofibromatosis type I|Neurofibromatosis type 1]] | *[[Neurofibromatosis type I|Neurofibromatosis type 1]] | ||
Line 41: | Line 41: | ||
* Skeletal abnormalities | * Skeletal abnormalities | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Multiple endocrine neoplasia type 1|MEN1]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Multiple endocrine neoplasia type 1|MEN1]]<ref>{{Cite journal | ||
| author = [[B. Gatta-Cherifi]], [[O. Chabre]], [[A. Murat]], [[P. Niccoli]], [[C. Cardot-Bauters]], [[V. Rohmer]], [[J. Young]], [[B. Delemer]], [[H. Du Boullay]], [[M. F. Verger]], [[J. M. Kuhn]], [[J. L. Sadoul]], [[Ph Ruszniewski]], [[A. Beckers]], [[M. Monsaingeon]], [[E. Baudin]], [[P. Goudet]] & [[A. Tabarin]] | |||
| title = Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database | |||
| journal = [[European journal of endocrinology]] | |||
| volume = 166 | |||
| issue = 2 | |||
| pages = 269–279 | |||
| year = 2012 | |||
| month = February | |||
| doi = 10.1530/EJE-11-0679 | |||
| pmid = 22084155 | |||
}}</ref> | |||
| | | | ||
* MENIN | * MENIN | ||
Line 62: | Line 74: | ||
* [[Somatotrope|Somatotroph]] [[pituitary adenoma]] | * [[Somatotrope|Somatotroph]] [[pituitary adenoma]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[BWS]] | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[BWS]]<ref>{{Cite journal | ||
| author = [[H. Segers]], [[R. Kersseboom]], [[M. Alders]], [[R. Pieters]], [[A. Wagner]] & [[M. M. van den Heuvel-Eibrink]] | |||
| title = Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients | |||
| journal = [[European journal of cancer (Oxford, England : 1990)]] | |||
| volume = 48 | |||
| issue = 17 | |||
| pages = 3249–3256 | |||
| year = 2012 | |||
| month = November | |||
| doi = 10.1016/j.ejca.2012.06.008 | |||
| pmid = 22796116 | |||
}}</ref> | |||
| | | | ||
* [[IGF2]], [[CDKN1C]], [[H19 (gene)|H19]] | * [[IGF2]], [[CDKN1C]], [[H19 (gene)|H19]] |
Revision as of 15:50, 25 September 2017
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma risk factors On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma risk factors |
Risk calculators and risk factors for Adrenocortical carcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The most potent risk factors in the development of adrenocortical cancer are Lynch syndrome, Beckwith-Wiedemann syndrome, Carney complex, Neurofibromatosis type 1, Multiple endocrine neoplasia type 1 (MEN1), and Carney complex.
Risk Factors
Risk factor associated with adrenocortical carcinoma are:
- Lynch syndrome
- Beckwith-Wiedemann syndrome (BWS)
- Carney complex
- Neurofibromatosis type 1
- Multiple endocrine neoplasia type 1 (MEN1)
Differential Diagnosis | Gene mutations | Clinical picture |
---|---|---|
Lynch syndrome | ||
Neurofibromatosis type 1 |
| |
MEN1[1] |
|
|
Carney complex | ||
BWS[2] |
References
- ↑ B. Gatta-Cherifi, O. Chabre, A. Murat, P. Niccoli, C. Cardot-Bauters, V. Rohmer, J. Young, B. Delemer, H. Du Boullay, M. F. Verger, J. M. Kuhn, J. L. Sadoul, Ph Ruszniewski, A. Beckers, M. Monsaingeon, E. Baudin, P. Goudet & A. Tabarin (2012). "Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database". European journal of endocrinology. 166 (2): 269–279. doi:10.1530/EJE-11-0679. PMID 22084155. Unknown parameter
|month=
ignored (help) - ↑ H. Segers, R. Kersseboom, M. Alders, R. Pieters, A. Wagner & M. M. van den Heuvel-Eibrink (2012). "Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients". European journal of cancer (Oxford, England : 1990). 48 (17): 3249–3256. doi:10.1016/j.ejca.2012.06.008. PMID 22796116. Unknown parameter
|month=
ignored (help)